These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8581373)

  • 1. Expression of monovalent and bivalent antibody fragments in Escherichia coli.
    Grant SD; Cupit PM; Learmonth D; Byrne FR; Graham BM; Porter AJ; Harris WJ
    J Hematother; 1995 Oct; 4(5):383-8. PubMed ID: 8581373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli.
    Pack P; Plückthun A
    Biochemistry; 1992 Feb; 31(6):1579-84. PubMed ID: 1737014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-chain Fv fusion proteins suitable as coating and detecting reagents in a double antibody sandwich enzyme-linked immunosorbent assay.
    Kerschbaumer RJ; Hirschl S; Kaufmann A; Ibl M; Koenig R; Himmler G
    Anal Biochem; 1997 Jul; 249(2):219-27. PubMed ID: 9212874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial expression of immunoglobulin fragments.
    Skerra A
    Curr Opin Immunol; 1993 Apr; 5(2):256-62. PubMed ID: 8507403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for generating multivalent and bispecific antibody fragments.
    Tomlinson I; Holliger P
    Methods Enzymol; 2000; 326():461-79. PubMed ID: 11036658
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification strategies for the production of single-chain antibody and T-cell receptor fragments in E. coli.
    Molloy PE; Graham BM; Cupit PM; Grant SD; Porter AJ; Cunningham C
    Mol Biotechnol; 1995 Dec; 4(3):239-45. PubMed ID: 8680930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments.
    Lu D; Jimenez X; Zhang H; Bohlen P; Witte L; Zhu Z
    J Immunol Methods; 2002 Sep; 267(2):213-26. PubMed ID: 12165442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and tumour-binding characterization of a chimeric anti-CEA Fab expressed in Escherichia coli.
    Chester KA; Robson L; Keep PA; Pedley RB; Boden JA; Boxer GM; Hawkins RE; Begent RH
    Int J Cancer; 1994 Apr; 57(1):67-72. PubMed ID: 8150543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Intervening Removable Affinity Tag (iRAT) System for the Production of Recombinant Antibody Fragments.
    Nomura N; Nomura Y; Sato Y; Iwata S
    Methods Mol Biol; 2021; 2247():77-103. PubMed ID: 33301113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
    Schultz J; Lin Y; Sanderson J; Zuo Y; Stone D; Mallett R; Wilbert S; Axworthy D
    Cancer Res; 2000 Dec; 60(23):6663-9. PubMed ID: 11118050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and production of novel tetravalent bispecific antibodies.
    Coloma MJ; Morrison SL
    Nat Biotechnol; 1997 Feb; 15(2):159-63. PubMed ID: 9035142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
    Venturi M; Seifert C; Hunte C
    J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and production of multimeric antibody fragments, focused on diabodies with enhanced clinical efficacy.
    Powers GA; Hudson PJ; Wheatcroft MP
    Methods Mol Biol; 2012; 907():699-712. PubMed ID: 22907381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression, isolation and purification of antibody fragments fused to maltose-binding protein in Escherichia coli].
    Brégégère F; Bedouelle H
    C R Acad Sci III; 1992; 314(12):527-32. PubMed ID: 1521173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.
    Lin Y; Pagel JM; Axworthy D; Pantelias A; Hedin N; Press OW
    Cancer Res; 2006 Apr; 66(7):3884-92. PubMed ID: 16585217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved procedure for the generation of recombinant single-chain Fv antibody fragments reacting with human CD13 on intact cells.
    Peipp M; Simon N; Loichinger A; Baum W; Mahr K; Zunino SJ; Fey GH
    J Immunol Methods; 2001 May; 251(1-2):161-76. PubMed ID: 11292491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of recombinant antibody fragments for membrane protein crystallization.
    Mir SH; Escher C; Kao WC; Birth D; Wirth C; Hunte C
    Methods Enzymol; 2015; 557():201-18. PubMed ID: 25950966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.